Biochemical and ultrasound tests for early diagnosis of active neuro-osteoarthropathy (NOA) of the diabetic foot

Diabetes Research and Clinical Practice

Volumn 58, Issue 1, 2002, Pages 1-9

  Piaggesi, A ^a   Rizzo, L ^a   Golia, F ^a   Costi, D ^b   Baccetti, F ^a   Ciaccio, S ^a   De Gregorio, S ^a   Vignali, E ^a   Trippi, D ^a   Zampa, V ^a   Marcocci, C ^a   Del Prato, S ^a  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITY OF PARMA   (Italy)

Author keywords

Charcot's foot; Diabetes mellitus; ICTP; Neuro osteoarthropathy; Quantitative ultrasound

Indexed keywords

ALKALINE PHOSPHATASE BONE ISOENZYME; COLLAGEN TYPE 1; DEOXYPYRIDINOLINE; OSTEOCALCIN; GLYCOSYLATED HEMOGLOBIN;

ADULT; AGED; ARTICLE; BONE DENSITY; BONE METABOLISM; BONE TURNOVER; CALCANEUS; CALCIUM BLOOD LEVEL; CLINICAL ARTICLE; DIABETIC FOOT; DIABETIC NEUROPATHY; DIAGNOSTIC PROCEDURE; EARLY DIAGNOSIS; FEMALE; HUMAN; MALE; NEUROPATHIC JOINT DISEASE; ULTRASOUND; BODY MASS; BONE; ECHOGRAPHY; INSULIN DEPENDENT DIABETES MELLITUS; METABOLISM; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; ONSET AGE; OSTEOARTHRITIS; OUTPATIENT; PATHOPHYSIOLOGY; REPRODUCIBILITY;

AGE OF ONSET; AGED; BODY MASS INDEX; BONE AND BONES; DIABETES MELLITUS, INSULIN-DEPENDENT; DIABETES MELLITUS, NON-INSULIN-DEPENDENT; DIABETIC FOOT; DIABETIC NEUROPATHIES; HEMOGLOBIN A, GLYCOSYLATED; HUMAN; MIDDLE AGE; OSTEOARTHRITIS; OUTPATIENTS; REPRODUCIBILITY OF RESULTS; SUPPORT, NON-U.S. GOV'T; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; HUMANS; MIDDLE AGED;

EID: 0036021076     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8227(02)00097-9     Document Type: Article

References (33)

1. Charcot foot
2. Long-term follow-up in diabetic Charcot feet with spontaneous onset
3. Charcot foot: an update on pathogenesis and management
4. Increased uptake of bone radiopharmaceutical in diabetic neuropathy
5. Osteopenia, neurological dysfunction and the development of Carcot neuroarthropathy
6. Impact of peripheral neuropathy on bone density in patients with type 1 diabetes
7. Utility of biochemical markers of bone
8. Longitudinal chages in ultrasound paramenters of the calcaneus
9. Bone loss and bone turnover in diabetes
10. Bone density in non-insulin-dependent diabetes mellitus. The Rotterdam study
11. Bone mineral density and bone metabolism in diabetes mellitus
12. The prediction of diabetic neuropathic foot using vibration perception threshold: a prospective study
13. Radiographic abnormalities in the feet of patients with diabetic neuropathy
14. Carefully monitored levothyroxin suppression therapy is not associated with bone loss in premenopausal women
15. Biochemical markers of bone turnover
16. Urinary pyridinium crosslinks of collages. Specific markers of bone resorption in metabolic bone disease
17. Bone protein and peptide assays in the diagnosis and management of skeletal diseases
18. Quantitative ultrasound of the calcaneus: an in vivo comparison with dual-energy x-ray absorptiometry and magnetic resonance imaging
19. Reconciling quantitative ultrasound of the calcaneus with X-ray-based measurement of the central skeleton
20. Measurement of markers of osteoclast and osteoblast activity in patients with acute and chronic diabetic Charcot neuroarthropathy
21. the natural history of acute Charcot's arthropathy in a diabetic foot specialty clinic
22. The Charcot foot in diabetes: six key-points
23. Ultrasound velocity and dual-energy X-ray absorptiometry in normal and pagetic bone
24. Bone mineral density in haemodialysis patients: a comparative study of dual-energy X-ray absorptiometry and quantitative ultrasound
25. Correlation between bone mineral density and circulating bone metabolic markers in diabetic patients
26. The effects of diabetes mellitus on the material property of human metatarsal bones
27. Urinary glycosylated, free and total pyridinoline and free and total deoxypyridinoline in diabetes mellitus
28. Bone mineral density, collagen type 1 alpha 1 genotypes and bone turnover in premenopausal women with diabetes mellitus
29. The urinary excretion of deoxypyridinium cross-links is higher in diabetic than in nondiabetic adolescents
30. Changes in bone turnover on deoxypyridinoline levels in diabetic patients
31. Bisphosphonates: a new treatment for diabetic Charcot neuroarthropathy?
32. Healing of Charcot's Joint by pamidronate infusion
33. Bisphosphonates in the treatment of Charcot neuroarthropathy: a double-blind randomised controlled trial